{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:18:17Z","timestamp":1790248697572,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.ejphar.2008.06.082","type":"journal-article","created":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T08:33:02Z","timestamp":1214641982000},"page":"219-223","source":"Crossref","is-referenced-by-count":34,"title":["Statins suppress MMP2 secretion via inactivation of RhoA\/ROCK pathway in pulmonary vascular smooth muscles cells"],"prefix":"10.1016","volume":"591","author":[{"given":"Manxiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.06.082_bib1","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1152\/ajplung.00378.2006","article-title":"Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension","volume":"293","author":"Arciniegas","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2008.06.082_bib2","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice","volume":"370","author":"Armitage","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2008.06.082_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cardiores.2007.06.004","article-title":"The importance of endothelin-1 for vascular dysfunction in cardiovascular disease","volume":"76","author":"Bohm","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2008.06.082_bib4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1440-1681.2006.04493.x","article-title":"Statins reduce macrophage inflammatory protein-1alpha expression in human activated monocytes","volume":"33","author":"Bruegel","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2008.06.082_bib5","doi-asserted-by":"crossref","first-page":"L154","DOI":"10.1152\/ajplung.00192.2006","article-title":"Mice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension","volume":"292","author":"Case","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2008.06.082_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1172\/JCI6539","article-title":"Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease","volume":"105","author":"Cowan","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.06.082_bib7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1183\/09031936.01.00084601","article-title":"Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension","volume":"18","author":"Frisdal","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2008.06.082_bib8","doi-asserted-by":"crossref","first-page":"L1105","DOI":"10.1152\/ajplung.00411.2006","article-title":"Regression of chronic hypoxic pulmonary hypertension by simvastatin","volume":"292","author":"Girgis","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2008.06.082_bib9","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/nprot.2006.425","article-title":"Preparation of primary cultured mesenteric artery smooth muscle cells for fluorescent imaging and physiological studies","volume":"1","author":"Golovina","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2008.06.082_bib10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/sj.bjp.0706408","article-title":"Inhibition of RhoA\/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension","volume":"146","author":"Guilluy","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.06.082_bib11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1160\/TH06-12-0744","article-title":"Cellular and molecular mechanisms of hypoxia-inducible factor driven vascular remodeling","volume":"97","author":"Hanze","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2008.06.082_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1183\/09031936.05.00027305","article-title":"Deciphering the \u201cmatrix\u201d in pulmonary vascular remodelling","volume":"25","author":"Hassoun","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2008.06.082_bib13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1161\/01.CIR.0000086463.15540.3C","article-title":"Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia","volume":"108","author":"Kuzuya","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.06.082_bib14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1183\/09031936.05.00072504","article-title":"Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension","volume":"25","author":"Lepetit","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2008.06.082_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1440-1843.2006.00778.x","article-title":"Pulmonary arterial hypertension: new insights and new hope","volume":"11","author":"Martin","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.ejphar.2008.06.082_bib16","first-page":"21","article-title":"Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide","volume":"21","author":"McNamara","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2008.06.082_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1465-9921-6-88","article-title":"Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease","volume":"6","author":"Morrell","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2008.06.082_bib18","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/01.ATV.0000186184.33537.48","article-title":"Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension","volume":"25","author":"Murata","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2008.06.082_bib19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1152\/japplphysiol.01028.2005","article-title":"Involvement of RhoA\/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat","volume":"100","author":"Nagaoka","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2008.06.082_bib20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.RES.0000261658.12024.18","article-title":"Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats","volume":"100","author":"Oka","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.06.082_bib21","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2174\/138945007781386893","article-title":"Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures","volume":"8","author":"Paraskevas","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2008.06.082_bib22","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","article-title":"Rho GTPases, statins, and nitric oxide","volume":"97","author":"Rikitake","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.06.082_bib23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.RES.0000126050.41296.8E","article-title":"Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3\/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension","volume":"94","author":"Schermuly","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.06.082_bib24","doi-asserted-by":"crossref","first-page":"592S","DOI":"10.1378\/chest.128.6_suppl.592S","article-title":"Involvement of hypoxia-inducible factor 1 in pulmonary pathophysiology","volume":"128","author":"Semenza","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2008.06.082_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/gb-2003-4-6-216","article-title":"Matrix metalloproteinases: old dogs with new tricks","volume":"4","author":"Somerville","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejphar.2008.06.082_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.RES.0000243584.45145.3f","article-title":"Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms","volume":"99","author":"Stenmark","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.06.082_bib27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0031-6997(24)01471-6","article-title":"Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells","volume":"52","author":"Touyz","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2008.06.082_bib28","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.mehy.2006.09.034","article-title":"Statins may ameliorate pulmonary hypertension via RhoA\/Rho-kinase signaling pathway","volume":"68","author":"Xing","year":"2007","journal-title":"Med. Hypotheses"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908006973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908006973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T21:52:50Z","timestamp":1738273970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908006973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":28,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0014299908006973"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.06.082","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}